| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Beta-Glucan | Hepatic Steatosis | 1 | PM | 34108131 | 📋 | A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice |
| Beta-Glucan | Hepatotoxicity | 1 | PM | 38444353 | 📋 | β-Glucan ameliorates cisplatin-induced oxidative and histological damage in kidney and liver of rats |
| Beta-Glucan | MAFLD | 4 | PM | 38328439 | 📋 | Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression |
| Beta-Glucan | MAFLD | 3 | PM | 38194248 | 📋 | Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota |
| Beta-Glucan | MAFLD | 2 | PM | 37685211 | 📋 | Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Beta-Glucan | MAFLD | 1 | PM | 36278802 | 📋 | Highland barley β-glucan alleviated western diet-induced non-alcoholic fatty liver disease via increasing energy expenditure and regulating bile acid metabolism in mice |
| Beta-Glucan | Non-Alcoholic Steatohepatitis | 1 | PM | 38333950 | 📋 | Effects of Oat β-Glucan and Inulin on Alleviation of Nonalcoholic Steatohepatitis Aggravated by Circadian Disruption in C57BL/6J Mice |
